PTU - Polskie Towarzystwo Urologiczne
list of articles:

EVALUATION OF PLASMINOGEN AND &alpha2-ANTIPLASMIN IN THE BLOOD OF PATIENTS FOLLOWING PROSTATIC SURGERY.
Article published in Urologia Polska 1995/48/3.

authors

Iza Iwan-Ziętek, Zbigniew Ziętek, Maria Kotschy, Ferdynand Tyloch
Z Katedry i Zakładu Patofizjologii Akademii Medycznej w Bydgoszczy
Kierownik: prof. dr hab. med. M. Kotschy
Z Katedry i Kliniki Urologii Akademii Medycznej w Bydgoszczy
p.o. kierownik: dr n. med. F. Tyloch.

summary

The plasminogen and ?2-antiplasmin in the blood of patients with prostatic carcinoma and
benign prostatic hyperplasia were examined. We observed after operation a similar decrease
the plasminogen and a2-antiplasmin. The decrease of plasminogen and ?2-antiplasmin can be
connected with the consumption these factors during fibrinolysis activation. The measurement
o ?2-antiplasmin and plasminogen could be usfull to predict a risk of haemorrghagic complica-
tion following prostatic surgery.

references

  1. 1. Al-Mondhiry H., Drago J., Barthomolew M. J.: The fibrinolytic system in experimental prosta-
  2. te tumor. Thromb. Haemost., 1986, 56, 133. ? 2. Aoki N.N. i wsp.: Congenital deficiency of oc2-
  3. plasmin inhibitor associated with severs haemorrhagic tendency. J. Clin. Invest, 1979, 663, 877. ?
  4. 3. Aranda A., Paramo J. A., Rocha E.\ Fibrinolytic activity in plasma after gynecological and urolo-
  5. gical surgery. Haemost., 1988, 18, 129. ? 4. Gordon-Smith I. C, Hickman J.A., Le Quesne LP.:
  6. Postoperative fibrinolytic activity. Brit. J. Surg., 1974, 61, 213. ? 5. Hasui Y. i wsp.: The relation-
  7. ship between cardiovascular complications of estrogen therapy and fibrinolysis in pateints with pro-
  8. static cancer. Prostate, 1992, 21,35. ? 6. Hundelshausen V.B. i wsp.: Blood coagulation and fibrino-
  9. lysis in prostate surgery. Fortschr. Med., 1992, 110, 126. ? 7. Iwan-Ziętek I. i wsp.: Tkankowy
  10. aktywator plazminogenu i jego inhibitor oraz inne parametry układu fibrynolizy we krwi chorych
  11. operowanych z powodu łagodnego przerostu gruczołu krokowego. Pol. Tyg. Lek., 1992, 49-50, 1096.
  12. - 8. Klufl C. i wsp.: The postoperative shutdown: a rapidly reverting acute phase patter for the fast
  13. acting inhibitor of tissue-type plasminogen activator after trauma. Scand. J. Clin. Lab. Invest, 1985,
  14. 45, 605 ? 9. Knight M. T. N., Dawson R., Melrose D. G.: Fibrinolytic response to surgery. Labile
  15. and stabile patterns and their relevance to postoperative deep vein thrombosis. Lancet 1977, 370. ?
  16. 10. Koiso A., Akaime U:, Nijima T.: Prevention of platelet aggregation in patients with prostatic
  17. cancer during estrogen theragy. Urol., 1992, 6, 579. ? 11. Kuzaka B., Cieślak A.: Skaza krwotoczna
  18. w przebiegu raka gruczołu krokowego z przerzutami. Urol. Pol., 1981,22,631.? 12. Levi M. iwsp.:
  19. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in
  20. vivo. Thromb. Haemost., 1993, 69, 141. ? 13. Lorente J.A. i wsp.: Time course of haemostatic
  21. abnormalities in sepsis and its reaction to outcome. Chest, 1993, 5, 1536. ? 14. Mellbring G. i wsp.:
  22. Tissue plasminogen activator concentratians in major abdominal surgery. Relationship to postopera-
  23. tive deeg vein thrombosis. Thromb. Res., 1984, 36, 331. ? 15. Ncmninga P.B., Teunenbraek A.,
  24. VeenhofC.H.N.: Low prevalence of coagulation and fibrinolytic activation in patients with primary
  25. untreated cancer. Thromb. Haemost., 1990, 64, 361. ? 16. Okajima K. i wsp.: Direct evidence for
  26. systemic fibringenolysis in patients with metastatic prostatic cancer. Thromb. Res., 1992, 66, 717.
  27. ? 17. PrimoseJ. H. i wsp.: Reduction in factor VII, fibrinogen and plasminogen activator inhibitor
  28. i activity after surgical treatment of morbid obesity. Thromb. Haemost.; 1992, 68, 396. ? 18. Rapa-
  29. port S.I., Chapman G.G., Ames S.B.: Coexistent hypercoagulability and acute hypofibrinogenemia in
  30. patient with prostatic carcinoma. Am. J. Med., 1959, 7, 144. ? 19. Tagnon H.J. i wsp.: The signi-
  31. ficance of fibrinolysis occuring in patients with metastatic cancer of prstate. Cancer, 1953, 6, 63. ?
  32. 20. Wolfart K, Farbiszewski R.: Zaburzenia w układzie krzepnięcia krwi i fibrynolizy po operacjach
  33. na gruczole krokowym. Pol.Tyg. Lek.. 1987, 43, 1673.